Eligibility in a cohort of patients with hidradenitis suppurativa treated with bimekizumab: Lessons and pitfalls in a real-world setting

  1. Ureña-Paniego, C.
  2. Haselgruber, S.
  3. Soto-Moreno, A.
  4. Cuenca-Barrales, C.
  5. Arias-Santiago, S.
  6. Molina-Leyva, A.
Revista:
Journal of the European Academy of Dermatology and Venereology

ISSN: 1468-3083 0926-9959

Año de publicación: 2024

Tipo: Carta

DOI: 10.1111/JDV.19921 GOOGLE SCHOLAR